Invention Grant
- Patent Title: Process for manufacturing peptide
-
Application No.: US18270509Application Date: 2021-12-29
-
Publication No.: US11993631B2Publication Date: 2024-05-28
- Inventor: Efrat Halbfinger
- Applicant: BioLineRx Ltd.
- Applicant Address: IL Modiln
- Assignee: BioLineRx Ltd.
- Current Assignee: BioLineRx Ltd.
- Current Assignee Address: IL ModiIn
- International Application: PCT/IL2021/051549 2021.12.29
- International Announcement: WO2022/144886A 2022.07.07
- Date entered country: 2023-06-30
- Main IPC: C07K7/00
- IPC: C07K7/00 ; C07K1/04 ; C07K1/10 ; C07K1/20

Abstract:
A large-scale process is described herein for preparing a cyclic peptide as described, comprising solid phase peptide synthesis of a linear peptide and cleaving it from the resin; oxidizing cysteine residues to form an intramolecular disulfide bond; and isolating the cyclic peptide, wherein:
(i) coupling uses diisopropylcarbodiimide and ethyl cyanohydroxyiminoacetate and/or N-hydroxybenzotriazole;
(ii) cleaving comprises contacting the peptide with a solution comprising TFA and dithioerythritol and/or dithiothreitol;
(iii) the peptide is precipitated after cleaving without prior concentration of the peptide by evaporation;
(iv) oxidizing comprises contacting an aqueous solution comprising at least 5 mg/mL peptide with hydrogen peroxide;
(v) isolating comprises loading the peptide on a reverse phase chromatography at up to 40 grams/kg column, and elution from the column;
(vi) isolating comprises lyophilization, followed by grinding the peptide; and/or
(vii) substitution of the resin is at least 0.3 milliequivalents/gram, and/or the resin is a Rink aminomethylstyrene resin.
(i) coupling uses diisopropylcarbodiimide and ethyl cyanohydroxyiminoacetate and/or N-hydroxybenzotriazole;
(ii) cleaving comprises contacting the peptide with a solution comprising TFA and dithioerythritol and/or dithiothreitol;
(iii) the peptide is precipitated after cleaving without prior concentration of the peptide by evaporation;
(iv) oxidizing comprises contacting an aqueous solution comprising at least 5 mg/mL peptide with hydrogen peroxide;
(v) isolating comprises loading the peptide on a reverse phase chromatography at up to 40 grams/kg column, and elution from the column;
(vi) isolating comprises lyophilization, followed by grinding the peptide; and/or
(vii) substitution of the resin is at least 0.3 milliequivalents/gram, and/or the resin is a Rink aminomethylstyrene resin.
Public/Granted literature
- US20240092827A1 PROCESS FOR MANUFACTURING PEPTIDE Public/Granted day:2024-03-21
Information query